Could a blend ever get a CAS number?

Defined mixtures of fixed composition can be registered in some circumstances, but that requires the composition to be fixed and specified by whoever registers it. A product whose proportions are undisclosed and supplier-defined does not meet that condition.

Is the absence of a PubChem record a red flag?

No - it is the expected result for any multi-component product and says nothing about quality. It is a red flag only if someone presents a blend name as though it were a chemical identifier.

How do I know two suppliers' versions match?

You cannot, from the name. You would need both certificates listing each component with its identifier and its mass, and even then you are comparing two disclosed compositions rather than relying on a shared name.

Does this apply to GLOW as well?

Identically. Neither name returns a PubChem record, neither has a CAS number, and both are supplier designations for a combination rather than names of substances.

KLOW (Blend)

KLOW Has No CAS Number, and It Cannot Have One

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-244 cited sources

Names like KLOW and GLOW identify a supplier's product, not a substance. A search of PubChem returns no record for either. Composition is defined by whoever assembles the vial, so two suppliers using the same name need not be selling the same thing.

Key facts

PubChem record for KLOW: None
PubChem record for GLOW: None
CAS registry number: None - registries index substances, not mixtures
INN: None
Components with PubChem records: All four
Composition defined by: The supplier
Consequence: Same name does not guarantee same contents
What to verify against instead: The four component identifiers

What a chemical identifier is for

Identifiers exist so that two people discussing a substance can be certain they mean the same one. A PubChem CID points at a defined structure. A CAS registry number points at a defined substance. An INN points at a defined active moiety recognised internationally. Each is assigned by a body that maintains the register, and each is stable: the number does not change because a supplier changed its formulation. That stability is the whole value, and it is exactly what a blend name does not have.

What a blend name is instead

A product designation. Searching PubChem by name for KLOW returns no compound, and so does GLOW - which is the correct behaviour rather than a gap in the database, because neither is a substance. Chemical registries index substances and defined mixtures with fixed compositions; an assembled multi-component product whose proportions are set by its assembler is not something a structure database can hold. There is no CAS number to look up, no INN, and no authority anywhere that defines what the name means.

Research material referenced

KLOW 80mg — third-party HPLC tested

View — £69.99

The practical consequence

Composition is whatever the supplier put in the vial. Two suppliers using the same name are under no obligation to use the same components, the same proportions or the same total mass, and nothing external constrains them. A result generated with one supplier's product is therefore not straightforwardly comparable with a result generated using another's, even where both are labelled identically - and neither is comparable with a third batch if the assembler changed the ratio between them. This is a materially weaker position than for a single compound, where a CID or CAS number pins the identity regardless of who supplied it.

What can be verified, and how

The components. All four have PubChem records: KPV at CID 125672, GHK-Cu at CID 71587328, TB-500 at CID 62707662 and BPC-157 at CID 9941957, with molecular weights of 342.43, 402.92, 889.0 and 1419.5 daltons respectively. Those identifiers are stable and checkable against any certificate. So the verification that is possible runs through the components and never through the product name, which is the reverse of the usual situation and worth being explicit about.

Why the name still does useful work

It is a convenient handle for a recurring combination, and there is nothing improper about a supplier naming a product. The error is treating the name as though it carried the guarantees a chemical identifier carries. A reader encountering the name in a forum post, a supplier listing or a search result has learned that someone is selling a combination of that description; they have not learned what is in it, and the only way to find out is a certificate listing the components with their identifiers and, ideally, their individual masses.

How this sits alongside the rest of the category

It is the identifier-level version of the limitation described throughout: a blend is a convenience of packaging rather than a defined entity. There is no published literature on this combination, no registry entry for it, no regulatory assessment of it, and no external definition of what the name denotes. All four components are supplied for laboratory research only and none of them, nor the blend, holds a marketing authorisation from the MHRA, EMA or FDA.

Quick reference

	A single compound	A named blend
PubChem CID	Yes	No
CAS number	Usually	No
Fixed composition	By definition	Set by the supplier
Comparable across suppliers	Yes, by identifier	Not guaranteed
What to verify against	The identifier	Each component's identifier

Extended research context

The KLOW (Blend) deep dive

Deep dive: a fourfold size range in one cake, and what partial dissolution hides

KLOW's components run from KPV at 342.43 daltons to BPC-157 at 1419.5 - a fourfold span, and the widest of any product in this catalogue. Solubility depends on size, charge distribution and hydrophobicity, and these four differ in all three, so a co-lyophilised cake containing all of them releases its components in sequence rather than together. The hazard follows directly and is easy to miss: a cake that looks partly dissolved is not uniformly partly dissolved. The smallest component may be entirely in solution while the largest has barely started. Draw from the vial at that moment and the sample is enriched in the fast components and depleted in the slow ones - a composition error with no visible sign at all, since the liquid looks like liquid. The instinctive response to visible solid makes it worse: shaking creates air-liquid interfaces, which is exactly where peptides unfold and then aggregate irreversibly. The correct response is diluent down the vial wall, gentle swirling, and more patience than a single peptide or even a three-component blend requires. There is a second asymmetry on top. Small peptides adsorb to glass and plastic more readily than large ones, so KPV is the component most likely to be lost to container walls at low concentration - a silent shift in the effective ratio that no certificate figure accounts for.

Deep dive: the cleanest possible comparison, which still cannot be run

KLOW is a strict superset of GLOW - the same three components plus KPV, at 80 mg against 70 mg. Product comparisons rarely have this structure. There is nothing in GLOW that KLOW lacks, so the difference between them reduces to a single question rather than a balance of trade-offs, and in principle comparing the two would isolate exactly what KPV contributes. In practice it cannot be done. The 10 mg difference in total might be 10 mg of added KPV with the other three unchanged, or it might be a redistribution across all four; both are consistent with the published figures, and neither product states its split. So any difference observed between the two could be KPV, or it could be a changed concentration of GHK-Cu, BPC-157 or TB-500. The experiment that the product pairing seems designed to permit is precisely the one the missing information forbids. This is the fixed-ratio limitation in its sharpest form: not that the format is unhelpful in general, but that it withholds the one number that would make the most natural question answerable.

Deep dive: two products from one hormone, in categories that never mention each other

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, isolated because that hormone does two functionally separable things - pigmentation through melanocortin receptors, and anti-inflammatory activity localised to its C-terminal end. KPV keeps the second and discards the first. Now look elsewhere in this catalogue: MT-2 is also an alpha-MSH derivative, and it is built around the melanocortin-receptor-binding core that KPV was specifically designed to leave behind. Two products, one parent hormone, opposite halves of its function, sitting in entirely separate product categories with nothing in either listing to indicate they are related. The size difference tracks the design logic. KPV at 342.43 daltons is three residues with no modifications, because an effect running through diffuse intracellular signalling can survive extreme truncation. MT-2 at 1024.2 daltons is seven residues plus a lactam bridge, a D-amino acid and two capped termini, because receptor engagement requires enough structure to present a specific surface. What a fragment needs to be depends entirely on what the retained function requires, and these two are as clean an illustration of that as this catalogue contains.

Research applications

▸Multi-component connective tissue research protocols
▸Comparative work on three-component versus four-component combinations
▸Co-lyophilisation and multi-component dissolution methodology
▸Copper peptide compatibility studies
▸Surface adsorption behaviour across a wide molecular size range
▸Anti-inflammatory and matrix pathway research

Handling checklist

✓Verify KPV as Lys-Pro-Val at 342.43 Da, CID 125672 - never by searching 'KPV'
✓Verify GHK-Cu against 402.92 Da (CID 71587328), not 340.38 for free GHK
✓Verify TB-500 against 889.0 Da, not 4.9 kDa for thymosin beta-4
✓Verify BPC-157 against 1419.5 Da
✓Expect four separate certifications - a single combined purity figure is a category error
✓Allow more dissolution time than a three-component blend; do not draw before it completes
✓Use low-binding consumables - KPV is the component most lost to surfaces
✓Store lyophilised, cold, dry and dark; the copper complex governs light protection

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Drawing from a partly dissolved four-component cake

Fix: Components dissolve in sequence across a fourfold size range. An early sample is enriched in fast components and depleted in slow ones, with no visible sign.

✗ Verifying the KPV component by searching 'KPV' in PubChem

Fix: That returns 2-oxo-5-phenylpentanoic acid at 192.21 Da, an unrelated compound. Search Lys-Pro-Val for CID 125672.

✗ Assuming the 10mg difference from GLOW is 10mg of KPV

Fix: Not stated. It could be added KPV with the others unchanged, or a redistribution across all four.

✗ Treating four component literatures as evidence about the blend

Fix: No published work addresses this combination or any subset of it. Summing separate literatures produces no evidence about a mixture.

✗ Adding a chelator because the blend contains copper

Fix: Unnecessary. None of the four components contains cysteine or methionine, so copper-catalysed oxidation has no substrate here.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Could a blend ever get a CAS number?: Defined mixtures of fixed composition can be registered in some circumstances, but that requires the composition to be fixed and specified by whoever registers it. A product whose proportions are undisclosed and supplier-defined does not meet that condition.
Is the absence of a PubChem record a red flag?: No - it is the expected result for any multi-component product and says nothing about quality. It is a red flag only if someone presents a blend name as though it were a chemical identifier.
How do I know two suppliers' versions match?: You cannot, from the name. You would need both certificates listing each component with its identifier and its mass, and even then you are comparing two disclosed compositions rather than relying on a shared name.
Does this apply to GLOW as well?: Identically. Neither name returns a PubChem record, neither has a CAS number, and both are supplier designations for a combination rather than names of substances.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More KLOW (Blend) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum